Contrast Media and Molecular Imaging

1.4(top 50%)

impact factor

1.7K(top 10%)

papers

20.6K(top 10%)

citations

63(top 10%)

h-index

1.4(top 50%)

impact factor

2.1K

all documents

21.8K

doc citations

96(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Classification and basic properties of contrast agents for magnetic resonance imaging	Contrast Media and Molecular Imaging	2009	472
2	Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium‐ and manganese‐based T₁ contrast agents	Contrast Media and Molecular Imaging	2009	437
3	Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents	Contrast Media and Molecular Imaging	2006	368
4	⁶⁸Ga‐PET: a powerful generator‐based alternative to cyclotron‐based PET radiopharmaceuticals	Contrast Media and Molecular Imaging	2008	288
5	Nanoparticle contrast agents for computed tomography: a focus on micelles	Contrast Media and Molecular Imaging	2014	268
6	How to determine free Gd and free ligand in solution of Gd chelates. A technical note	Contrast Media and Molecular Imaging	2006	249
7	A review of responsive MRI contrast agents: 2005–2014	Contrast Media and Molecular Imaging	2015	168
8	Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview	Contrast Media and Molecular Imaging	2019	168
9	Photoacoustic tomography: fundamentals, advances and prospects	Contrast Media and Molecular Imaging	2011	167
10	Long‐term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium‐enhanced MRI scans: case report and implications	Contrast Media and Molecular Imaging	2007	161
11	Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow	Contrast Media and Molecular Imaging	2006	156
12	Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas	Contrast Media and Molecular Imaging	2018	141
13	Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermal therapy	Contrast Media and Molecular Imaging	2014	131
14	Imaging of the lymphatic system: new horizons	Contrast Media and Molecular Imaging	2006	128
15	Multimodality imaging techniques	Contrast Media and Molecular Imaging	2010	116
16	Assessing cytotoxicity of (iron oxide‐based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes	Contrast Media and Molecular Imaging	2009	114
17	Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents	Contrast Media and Molecular Imaging	2010	113
18	Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T₂ contrast agent with tunable proton relaxivities	Contrast Media and Molecular Imaging	2012	113
19	Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test and photothermal theranostics	Contrast Media and Molecular Imaging	2011	111
20	Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging	Contrast Media and Molecular Imaging	2015	109
21	Localization, mechanism and reduction of renal retention of technetium‐99m labeled epidermal growth factor receptor‐specific nanobody in mice	Contrast Media and Molecular Imaging	2011	108
22	Specific E-selectin targeting with a superparamagnetic MRI contrast agent	Contrast Media and Molecular Imaging	2006	107
23	Surface functionalization of magnetic iron oxide nanoparticles for MRI applications – effect of anchoring group and ligand exchange protocol	Contrast Media and Molecular Imaging	2011	104
24	Gold nanorods as molecular contrast agents in photoacoustic imaging: the promises and the caveats	Contrast Media and Molecular Imaging	2011	104
25	Evans Blue Dye: A Revisit of Its Applications in Biomedicine	Contrast Media and Molecular Imaging	2018	104
26	A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging	Contrast Media and Molecular Imaging	2010	103
27	High‐throughput screening of chemical exchange saturation transfer MR contrast agents	Contrast Media and Molecular Imaging	2010	103
28	Development and validation of a smoothing‐splines‐based correction method for improving the analysis of CEST‐MR images	Contrast Media and Molecular Imaging	2008	102
29	Gold nanocages as contrast agents for photoacoustic imaging	Contrast Media and Molecular Imaging	2011	100
30	Sortase A‐mediated site‐specific labeling of camelid single‐domain antibody‐fragments: a versatile strategy for multiple molecular imaging modalities	Contrast Media and Molecular Imaging	2016	100
31	Dendritic PARACEST contrast agents for magnetic resonance imaging	Contrast Media and Molecular Imaging	2007	96
32	A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging	Contrast Media and Molecular Imaging	2015	95
33	Effect of anesthesia carrier gas on in vivo circulation times of ultrasound microbubble contrast agents in rats	Contrast Media and Molecular Imaging	2011	94
34	Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on ⁶⁸Ga-Pentixafor PET/CT Imaging Using Deep Learning Methods	Contrast Media and Molecular Imaging	2018	93
35	Cobalt nanoparticles as a novel magnetic resonance contrast agent—relaxivities at 1.5 and 3 Tesla	Contrast Media and Molecular Imaging	2008	92
36	Cellular labeling with Gd(III) chelates: only high thermodynamic stabilities prevent the cells acting as ‘sponges’ of Gd3+ ions	Contrast Media and Molecular Imaging	2006	89
37	Multimodal Molecular Imaging: Current Status and Future Directions	Contrast Media and Molecular Imaging	2018	88
38	Imaging of angiogenesis using Cadence™ contrast pulse sequencing and targeted contrast agents	Contrast Media and Molecular Imaging	2008	87
39	Incorporation of an apoE‐derived lipopeptide in high‐density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis	Contrast Media and Molecular Imaging	2008	87
40	Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging	Contrast Media and Molecular Imaging	2019	86
41	Ultra‐small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI	Contrast Media and Molecular Imaging	2011	84
42	Antibody‐functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of ⁸⁹Zr‐labeled cetuximab in mice	Contrast Media and Molecular Imaging	2013	84
43	How to measure the transmetallation of a gadolinium complex	Contrast Media and Molecular Imaging	2010	83
44	Use of perfluorocarbon nanoparticles for non‐invasive multimodal cell tracking of human pancreatic islets	Contrast Media and Molecular Imaging	2011	83
45	Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M	Contrast Media and Molecular Imaging	2007	80
46	Imaging of Her2‐targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID‐detected magnetic relaxometry and MRI	Contrast Media and Molecular Imaging	2012	80
47	Efficient stem cell labeling for MRI studies	Contrast Media and Molecular Imaging	2008	79
48	Quantitative Radiomics: Impact of Pulse Sequence Parameter Selection on MRI-Based Textural Features of the Brain	Contrast Media and Molecular Imaging	2018	79
49	Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges	Contrast Media and Molecular Imaging	2017	78
50	Enzyme‐responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome	Contrast Media and Molecular Imaging	2007	77

Scientometrics

Overviews

Citing Bodies

Contrast Media and Molecular Imaging

Top Articles